SEATTLE--(BUSINESS WIRE)--Pacific Biometrics, Inc. (OTCBB:PBME) (“PBI”) has been awarded a contract by a global central laboratory to provide supporting laboratory data for a multinational pharmaceutical company (the “Sponsor”). This contract is related to the clinical development of an innovative new treatment for osteoporosis.
